share_log

RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $32

Benzinga Real-time News ·  Nov 7, 2022 10:02

RBC Capital analyst Ben Hendrix maintains Select Medical Hldgs (NYSE:SEM) with a Outperform and lowers the price target from $36 to $32.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment